HomeOwner SearchCategory Search
Visit USCOA Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR (octreotide acetate) for the treatment of Recurrent and/or Refractory Meningiomas in Adult Patients
Text Registration
Copyright Title
A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR (octreotide acetate) for the treatment of Recurrent and/or Refractory Meningiomas in Adult Patients
Status
Published
on 6 Sept 2018
Year of Creation
2018
Copyright Claimant
Emely Nguyen
Registration Number
TX0008640572
on 6 Sept 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008640572) dated 6 Sept 2018, pertains to an electronic file (eService) titled "A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR (octreotide acetate) for the treatment of Recurrent and/or Refractory Meningiomas in Adult Patients" created in 2018. The copyright holder is Emely Nguyen, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Emely Nguyen.
Application Details
Registration Number
TX0008640572
Registration Date
9/6/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR (octreotide acetate) for the treatment of Recurrent and/or Refractory Meningiomas in Adult Patients
Author Statement: Emely Nhi Thi Ai Nguyen Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.